"This costing statement considers the cost implications of implementing the recommendations made in Drug allergy: diagnosis and management of drug allergy in adults, children and young people (NICE clinical guideline 183). 1.2 A costing statement of resource effects has been produced for this guideline as variation in clinical practice across the country means users should consider and assess the impact locally."
Costing statement: Drug allergy: diagnosis and management of drug allergy in adults, children
and young people. Implementing the NICE guideline on Drug allergy in adults, children and young people (CG183)
NICE
September 2014
Read more here.
No comments:
Post a Comment